Thursday, July 9, 2026

pharma · Amyotrophic Lateral Sclerosis (ALS) · COYA

Coya Therapeutics

Coya Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Paris, FR HQ
2014 Founded
50 Employees
Public company Type
COYA · NYSE Ticker
Company details
Status
Public
HQ
Paris, FR
Founded
2014
Employees
50
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

Coya Therapeutics projects

0 ClinicalTrials.gov programs sponsored by Coya Therapeutics.

Coya Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Coya Therapeutics have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.